Hpv-associated Oropharyngeal Cancer
📧 Sign up to get email alerts when something new happens for Hpv-associated Oropharyngeal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Ipilimumab, Nivolumab, and Radiation Therapy in Treating Patients With HPV Positive Advanced Oropharyngeal Squamous Cell Carcinoma [Phase 2]
Phase 2 clinical trial evaluating the combination of ipilimumab, nivolumab, and radiation therapy in patients with HPV-positive advanced oro…
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: HYHOPE: De-intensified Hypofractionated Radiation Therapy for HPV-associated Oropharynx Cancer [Phase 1]
Phase 1 trial evaluating de-intensified hypofractionated radiation therapy for HPV-associated oropharyngeal cancer has completed, with resul…
-
CLINICAL_TRIALS trial_result · 2025-09-17Clinical Trial Update: Evaluating a Decreased Dose of Radiation Therapy to the Elective Neck for the Treatment of HPV-Related Oropharyngeal Cancer, ENLIGHT Trial [Phase 2]
Phase 2 ENLIGHT trial evaluating reduced radiation dose to the elective neck in HPV-associated oropharyngeal cancer (Stage I-II); currently …
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: The Sinai Robotic Surgery Trial in HPV Positive Oropharyngeal Squamous Cell Carcinoma (SCCA) (SIRS TRIAL) [NA]
This update reports the completion of the Sinai Robotic Surgery Trial (SIRS) in HPV-positive oropharyngeal squamous cell carcinoma and notes…
-
CLINICAL_TRIALS trial_result · 2024-04-08Clinical Trial Update: Evaluation of De-escalated Adjuvant Radiation Therapy for Human Papillomavirus (HPV)-Associated Oropharynx Cancer [Phase 3]
Phase 3 trial evaluating de-escalated adjuvant radiation therapy for HPV-associated oropharyngeal cancer has completed and posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-10-12Clinical Trial Update: OPSCC N0 Nodal Control With Reduced IMRT [NA]
Clinical trial update for OPSCC with reduced IMRT in HPV-associated disease; study terminated with posted results.